Credit Agricole S A Tg Therapeutics, Inc. Transaction History

Credit Agricole S A

  • $22.8 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$6.27 - $8.65 $8.2 Million - $11.3 Million
-1,307,428 Closed
0 $0
Q4 2018

Feb 13, 2019
SELL
$3.44 - $5.76 $26,047 - $43,614
-7,572 Reduced 0.58%
1,307,428 $5.36 Million
Q3 2018

Nov 13, 2018
BUY
$5.15 - $14.0 $6.77 Million - $18.4 Million
1,315,000 New
1,315,000 $7.36 Million

Others Institutions Holding TGTX

# of Institutions
338
Shares Held
87.6M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.23B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Credit Agricole S A Portfolio

Follow Credit Agricole S A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Agricole S A, based on Form 13F filings with the SEC.

News

Stay updated on Credit Agricole S A with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email